ClinicalTrials.Veeva

Menu

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk (SCORES)

Northwell Health logo

Northwell Health

Status

Enrolling

Conditions

Prodromal Symptoms
Psychosis
Prodromal Schizophrenia

Treatments

Behavioral: SCORES (Specific COgnitive Remediation with Support)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05131035
21-0832, 23-0500
R33MH123574 (U.S. NIH Grant/Contract)
R61MH123574 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, represents a vulnerability factor for psychosis. This remotely-delivered intervention combining targeted cognitive training exercises and group support was developed to directly impact processing speed, and at the same time, boost motivation and engagement in adolescents at risk for schizophrenia and other psychotic disorders.

Full description

This study evaluates the effectiveness of a cognitive remediation (CR) program plus group coaching and support designed to improve processing speed and, in turn, social functioning and attenuated positive symptoms in individual considered Clinical High Risk for psychosis. The SCORES (Specific COgnitive REmediation with Support) intervention is a novel Cognitive Remediation program combined with group coaching, performance-based rewards, game-like tasks, and educational elements to increase engagement and retention. The study is funded by a R61/R33 award. In the R61 phase, all participants were asked to complete 40 hours of Cognitive Remediation or brain training (4 hours per week/10 weeks) with a mid-point assessment (at 5 weeks) to determine the training dose needed to impact processing speed as measured by the Matrics Cognitive Consensus Battery. The current R33 (Phase 2) will look to replicate the results of the R61 and assess the specificity of the targeted intervention with the addition of a non-speeded cognitive training group..

Enrollment

54 estimated patients

Sex

All

Ages

14 to 20 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meet Clinical High Risk (CHR) criteria on the Structured Interview for Psychosis Risk Syndromes, defined by the presence of at least one attenuated positive symptom at a moderate to severe level
  • A score representing 0.5 SD below the mean on Animal Naming, Trails A or BACS: Symbol Coding from the MATRICS Consensus Cognitive Battery (MCCB).

Exclusion criteria

  • Any DSM 5 Schizophrenia-Spectrum diagnosis
  • Non-English speaking
  • Past or current history of a clinically significant central nervous system disorder (e.g., seizure disorder)
  • Estimated IQ<70
  • Significant head injury
  • Significant substance abuse
  • Significant visual or auditory impairment.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

54 participants in 2 patient groups

Speeded Cognitive Training
Experimental group
Description:
Participants in this condition will complete 40 hours of Cognitive Remediation with a mid-point assessment (20 hours/5 weeks) to determine the impact of speeded cognitive training tasks on cognition and social function.
Treatment:
Behavioral: SCORES (Specific COgnitive Remediation with Support)
Non-Speeded Cognitive Training
Active Comparator group
Description:
Participants in this condition will complete 40 hours of Cognitive Remediation with a mid-point assessment (20 hours/5 weeks) to determine the impact of non-speeded cognitive training tasks on cognition and social function.
Treatment:
Behavioral: SCORES (Specific COgnitive Remediation with Support)

Trial contacts and locations

1

Loading...

Central trial contact

Danielle McLaughlin, M.A.; Ricardo E Carrion, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems